Trial Profile
Pneumococcal vaccination of rheumatoid arthritis patients in immunomodulatory therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Sep 2017
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms Immunovax_RA
- 09 Sep 2017 Status changed from recruiting to completed.
- 22 Jan 2015 New trial record